We own our pharmacy and platform. How do we turn that into a growth advantage?

What does vertical integration actually change about your CAC ceiling?

Every third party between the click and the patient — fulfillment partner, platform vendor, pharmacy intermediary — takes a margin. Owning those layers removes their markups from your cost per order, which raises contribution margin per first order and per refill. Contribution margin, plus retention, sets the CAC ceiling: the maximum you can spend to acquire a patient and still fund the next one.

That is the structural advantage: not a lower CAC, but a higher ceiling. An integrated operator can hold a bid, a channel, or a condition open longer than a competitor paying retail for fulfillment — and can profitably acquire at a first-order loss when the refill curve, which it also owns, pays it back. The ceiling is only real if you can measure it, which is where most integrated operators stop.

How do term structure and BUD-date-aware shipping intervals work as a cash and retention lever?

Compounded and dispensable preparations carry a beyond-use date. Shipping intervals aligned to that date — and to the refill cadence the prescriber and the patient actually follow — protect product quality, cut waste and remakes, and make every shipment a planned retention touchpoint rather than an unexpected charge. Term structure works the same direction: treatment plans and subscription terms defined up front give the patient a predictable rhythm and give the business a predictable revenue curve.

The cash effect is quieter but real. Plannable shipment cadence makes inventory turns and the cash conversion cycle plannable with it — procurement, fulfillment labor, and shipping spend all ride a forecast instead of a queue. An integrated operator can do this; a business renting its pharmacy and platform cannot, because it does not control the calendar.

Where do integrated operators still leak margin?

Average-cost allocation. Spreading fulfillment cost as a flat average hides the conditions and orders that are quietly unprofitable, so acquisition spend keeps flowing to them. Activity-based actuals are the fix.

Waste, remakes, and expiring product. Shipping that ignores beyond-use dates and refill reality produces discardable product and repeat fulfillment labor — margin that leaves through the pharmacy door and never appears on the acquisition report.

Discounting the advantage away. Promotions sized against competitors' economics rather than your own ceiling give away the integration margin that funded them. The ceiling exists to bid against, not to rebate.

Spend on weak-retention cohorts. Blended CAC targets let strong refill conditions subsidize weak ones. Without per-cohort ceilings, budget drifts to wherever volume is easiest, not where the stack earns the most.

Uninstrumented ops. Manual handoffs between platform, EMR, and pharmacy add labor cost and error rates that read as margin leakage downstream. The data plumbing is itself a margin lever.